Skip to content

Effect of symbiotic on Immunotherapy

Clinical trial to evaluate the impact of synbiotic on the clinical and immunological efficiency of allergen immunotherapy in patients with allergic rhinitis and compared with placebo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015120123235N4
Enrollment
30
Registered
2016-08-29
Start date
2015-08-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perennial allergic rhinitis. Other allergic rhinitis

Interventions

Intervention 1: In intervention group synbiotic capsule give once a day for two month. Intervention 2: In control group placebo capsule give once a day for two month with immunotherapy. Intervention 3
Treatment - Drugs
In intervention group synbiotic capsule give once a day for two month

Sponsors

Vice chancellor for research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria:patients with persistent allergic rhinitis; Mashhad residents and surrounding towns; Have a positive skin test with Aeroallergen; Cooperate in projects Exclusion criteria: A history of autoimmune disease; Systemic corticosteroids or immunosuppressive drugs consumption and effective on immune system; Pregnant Women; Patients with immunodeficiency; Patients with malnutrition; Use Antibiotic during synbiotic consumption

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of life. Timepoint: Before the intervention and two month later. Method of measurement: Snot 22 questionnaire.;IL4. Timepoint: Before the intervention and two month later. Method of measurement: Flow cytometry.;T-reg. Timepoint: Before the intervention and two month later. Method of measurement: Flow cytometry.;IFN- gamma. Timepoint: Before the intervention and two month later. Method of measurement: Flow cytometry.

Secondary

MeasureTime frame
Systemic reactions to immunotherapy. Timepoint: At every turn immunotherapy. Method of measurement: Clinical.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Moazzen, MD

Mashhad University of Medical Sciences

n.moazzen@gmail.com+98 51 3801 2830

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026